Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis - Wikidata - wikimedia - TriplyDB

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis

http://www.wikidata.org/entity/Q35108310

about

DNA methylation biomarkers: cancer and beyond Quantitative and Qualitative Analysis of Circulating Cell-Free DNA Can Be Used as an Adjuvant Tool for Prostate Cancer Screening: A Meta-Analysis Cell-free DNA as a diagnostic marker for cancer: current insights Genome-wide epigenomic profiling for biomarker discovery Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer Hypomethylation of dual specificity phosphatase 22 promoter correlates with duration of service in firefighters and is inducible by low-dose benzo[a]pyrene Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis Prostate cancer epigenetics and its clinical implications Novel tools for prostate cancer prognosis, diagnosis, and follow-up A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection The Effects of Lycopene on the Methylation of the GSTP1 Promoter and Global Methylation in Prostatic Cancer Cell Lines PC3 and LNCaP.Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients.Detection of OSR2, VAV3, and PPFIA3 Methylation in the Serum of Patients with Gastric Cancer.Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer.The epigenetic promise for prostate cancer diagnosis.Risk stratification in prostate cancer screening.APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer.Prognostic DNA methylation markers for prostate cancer.The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.Epigenetic biomarkers in the blood of patients with urological malignancies.DNA methylation profiles in cancer diagnosis and therapeutics.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Towards DNA methylation detection using biosensors.GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients.Hydroxymethylation- and methylation-sensitive tag sequencing: how will this technology change clinical applications of DNA methylation profiling?Epigenetic markers of prostate cancer in plasma circulating DNA.Clinical Significance of Measuring Global Hydroxymethylation of White Blood Cell DNA in Prostate Cancer: Comparison to PSA in a Pilot Exploratory Study.A suite of DNA methylation markers that can detect most common human cancers.Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies.Epigenetics and Precision Oncology.Developing DNA methylation-based diagnostic biomarkers.A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA.Surgical systems biology and personalized longitudinal phenotyping in critical care

P2860

Q26996421-A64336D4-F7A7-4C1B-ACA5-0138BA77B241 Q28072148-DDFC3DCD-750C-4178-8F3A-95BB9C0C228F Q28074556-F7ABDC58-30E9-4E68-9C19-435EFE3E32CA Q28080102-6168DE26-ADB9-41F8-B65E-8C7393BD803D Q28087759-0C0E9C14-5D68-411E-B679-E183FCC3BED6 Q28386421-1C48AC9D-A20B-4FEF-821C-0943DCFA7D77 Q28541425-6B5E92A1-D9C1-4293-A8CB-8383D03E7E25 Q28829460-8CFD15C2-D36C-4AD3-A1EC-74B397B2AA07 Q33625338-242084E6-127E-4122-8424-27C7BBFE44CD Q34294196-9256241D-34B4-4B6B-B3AC-66E5A0C3C835 Q34441679-FFA93F11-0D95-4766-967E-42CD541B1917 Q35000853-1EB138CC-F201-4ED8-9229-20357301464A Q36197208-8754CD2A-30D2-4D43-BC9A-6A6A320A1D7E Q36819379-B3EA5738-53C5-480A-9C39-6A89BF0265BD Q37629548-7F4E27D9-6083-4DD4-88D8-896274690159 Q37720392-1A0452EF-A8BF-4E0F-8277-32634B5D3E6A Q37967574-6958DD07-4851-4F63-B5A6-8CD46756347C Q38068114-2A0CD057-2C53-4800-B1C8-37934D477C51 Q38072660-0AD04BB1-349D-40BB-9A72-D59BAA8AFC73 Q38216129-E1602A70-3818-4A0A-89FD-CB579BE4CA95 Q38242279-25FAF5DE-F705-44FB-B4AD-879FD6692AF2 Q38252624-59F32AC1-A53D-4BE0-BEF2-512FE2802E7F Q38269155-A92C6867-DA27-456B-987E-41196B28C596 Q38365422-92ED3643-9463-4CCC-8377-4964B32682DA Q38650593-63199572-732D-4080-8343-C6DB4CC25BA9 Q38833395-ACE229E1-85FF-4736-B55F-A92A7F0A01A7 Q38972400-E727D481-61C9-4D03-A170-E747593ACE6F Q41339288-E6EB6B48-A3EC-4977-9AE7-3054237256CC Q41672565-E0120008-B205-4BAF-9E92-BF6212171118 Q42256326-80D0D3E5-FA04-4FF1-B263-20EF9563325A Q45276310-D0624B38-2AB3-4181-BF3A-74B45AFEF65F Q45342371-3C5539A1-DBCF-4BA3-9AAC-F16EA314A747 Q47119316-CE60B98A-9230-494E-88D3-BA865B591EC5 Q47356569-4AEAB6A7-BBAF-4F8C-AD9B-5393017EC724 Q49710514-3694493F-DDD6-4839-904F-BA4D4DCA5916 Q50020927-81F0F598-7522-4ED8-8678-90A77E280676 Q52370391-52F42CBA-F60D-4398-B947-0F450D872BA8 Q55517990-F5DEF363-E5D4-4B92-9F84-F17AABDDF36D Q58045562-CB4E5725-3133-459B-80BC-130FE9AE2C60

P2860

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis

http://www.wikidata.org/entity/Q35108310

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Measurement of GSTP1 promoter ...... PSA screening: a meta-analysis

@ast

Measurement of GSTP1 promoter ...... PSA screening: a meta-analysis

@en

type

label

Measurement of GSTP1 promoter ...... PSA screening: a meta-analysis

@ast

Measurement of GSTP1 promoter ...... PSA screening: a meta-analysis

@en

prefLabel

Measurement of GSTP1 promoter ...... PSA screening: a meta-analysis

@ast

Measurement of GSTP1 promoter ...... PSA screening: a meta-analysis

@en

P1433

Q35108310-A0A18AC0-99A4-4A67-B4E1-2A5DE8FD5DC6

P1476

Q35108310-FD15E8D6-2B44-4671-A70D-988BA2F388AD

P2093

Q35108310-36720ED1-2BC8-4EA2-A598-FA17D501F91C

Q35108310-71A4772E-68E3-4518-BAA4-99D17B90AA0E

Q35108310-9AFAD89D-CEA0-401F-989B-E9C0CAAECCB9

Q35108310-B3C5E11F-F85D-406F-BE82-31E0C4980705

Q35108310-B92851F0-4229-4917-A020-194AB1CF9C64

Q35108310-E26C24EF-1716-41B0-86FF-5EE2F958EB0C

P2860

Q35108310-252401D2-611B-4E89-81AB-EEB8C4F0F65F

Q35108310-43E3D750-3EDD-4936-9782-F4EA26998B65

Q35108310-4D46836B-F4D9-4447-8F2C-EB5CA8EB503E

Q35108310-52810976-D2E6-44BC-963F-71EF920B433B

Q35108310-5A66B8D2-4047-4F68-B449-DDA07A3FCC45

Q35108310-5D871503-F170-4ED2-A8D4-8D182AAE1B67

Q35108310-66982548-388C-4430-923D-CBCAFB5FFA60

Q35108310-66DBFD70-F6EA-4F6E-A7E0-D9EB42D741D7

Q35108310-6A1DC14A-35DF-4AED-B9EC-93F448A8FE20

Q35108310-6F124A1E-F8E3-4898-BE79-3EBE2D74A9DC

P2888

Q35108310-717BEF16-DC46-4764-BC32-099671529E6A

P304

Q35108310-2E32324D-EC16-45A2-97E4-3AD290E553E7

P31

Q35108310-5e50246e-8b5a-483f-a034-fa3bf33b9d3b

Q35108310-840FECED-6BBD-46E8-B136-F845D8644CCD

P356

Q35108310-2329E62F-A8B5-4C93-BA38-7515770D4242

P407

Q35108310-57109D3E-3504-4DC2-B1C9-E27E6CC07AF2

P433

Q35108310-82A6117D-EAEF-45B8-8B8E-C54AC1A676A2

P478

Q35108310-A330627C-240D-455D-A665-3A5DC8416AA4

P577

Q35108310-00329C42-893E-4A6E-BEB7-1B48664581DA

P5875

Q35108310-DA651A5B-A440-4DCF-9D14-67ABB6AE35A4

P698

Q35108310-512540DC-4247-471E-9D60-0DEDE3F759A8

P932

Q35108310-D6BCCE49-D89D-4FF8-85FC-374FD5EC4374

P356

P1433

British Journal of Cancer

P1476

Measurement of GSTP1 promoter ...... PSA screening: a meta-analysis

@en

P2093

E Giovannucci

http://www.w3.org/2001/XMLSchema#string

J Welge

http://www.w3.org/2001/XMLSchema#string

P Mallick

http://www.w3.org/2001/XMLSchema#string

S-M Ho

http://www.w3.org/2001/XMLSchema#string

T Wu

http://www.w3.org/2001/XMLSchema#string

W-Y Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Laser-fluorescence microsatellite analysis and new results in microsatellite analysis of plasma/serum DNA of cancer patients.

Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer.

GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.

CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.

Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy

Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.

High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.

Management of cancer of the prostate.

Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.

P2888

P304

65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.143

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51202772

http://www.w3.org/2001/XMLSchema#string

P698

21654682

http://www.w3.org/2001/XMLSchema#string

P932

3137397

http://www.w3.org/2001/XMLSchema#string